Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy-Reference-Cited by-同舟云学术

Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy

Published:2019-04-17 Issue:7 Volume:195 Page:648-658
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Kitagawa Mio,Someya Masanori,Hasegawa Tomokazu,Mikami Toshihiko,Asaishi Kazuaki,Hasegawa Tadashi,Matsumoto Yoshihisa,Kutomi Goro,Takemasa Ichiro,Sakata Koh-ichi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-019-01468-z.pdf

Reference29 articles.

1. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet 378(9804):1707–1716

2. Wapnir IL, Anderson SJ, Mamounas EP et al (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24(13):2028–2037

3. Oouchi A, Sakata K, Masuoka H et al (2009) The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy. Breast Cancer 16(1):49–57

4. Yoshida T, Takei H, Kurosumi M et al (2010) True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment. Breast J 16(2):127–133

5. Ishitobi M, Ohsumi S, Inaji H et al (2012) Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index. Cancer 118(18):4385–4393

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the DNA damage response pathway in the infected gastric tissue with Helicobacter pylori: a case-control study;The Journal of Infection in Developing Countries;2023-08-31

2. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer;BMC Bioinformatics;2023-02-10

3. X-Ray Repair Cross Complementing 4 (XRCC4) Genetic Single Nucleotide Polymorphisms and the Liver Toxicity of AFB1 in Hepatocellular Carcinoma;Aflatoxin B1 Occurrence, Detection and Toxicological Effects;2020-06-03